Knowledge Content
#### 1. Targeted Breakthrough of the Myostatin Chain
Myostatin is a natural brake that inhibits excessive muscle growth. YK11 competitively binds to myostatin receptors, preventing them from transmitting inhibitory signals. Experiments have shown that after eight weeks of YK11 use, myostatin gene expression decreased by 40%, muscle satellite cell activity increased by 2.3-fold, and even at low training volumes, slow-twitch fiber cross-sectional area increased by 18%. This treatment is particularly suitable for individuals seeking to build muscle without weight after joint injuries.
#### 2. Muscle-building Advantages of Low Axis Inhibition
Unlike traditional steroids, YK11 disrupts the hypothalamic-pituitary-gonadal axis by only one-fifth the amount of testosterone. At a weekly dose of 10-15mg, endogenous testosterone secretion decreases by less than 20%, eliminating the need for additional HCG therapy to protect gonads. Estrogen conversion is also extremely low (with virtually no risk of breast hyperplasia), making it suitable for natural bodybuilders seeking to maintain muscle mass over the long term.
#### 3. A Muscle "Preservative" During Fat Loss
During a caloric deficit, YK11 reduces muscle loss by 60% by upregulating the expression of anti-catabolic proteins (such as MGF) in muscle. It also slightly elevates adiponectin levels (promoting lipolysis), achieving the goal of "losing fat without losing muscle" in preparation for competitions. Studies have shown that when combined with calorie restriction, users can achieve a net gain of 1.2kg in muscle mass while reducing body fat by 3%.
YK11's unique approach lies in its ability to not simply amplify androgen effects but rather address the inherent "limitations" to muscle growth at the genetic level. This allows it to demonstrate precision unmatched by traditional medications for rehabilitation, low-side effect muscle growth, and pre-competition body shaping.
